Conclusion
The purpose of this study was to report the reasons older adults (or their surrogates) declined participation in two deprescribing clinical trials. Given the growing evidence that deprescribing can be conducted safely and effectively, pragmatic trial approaches with alternative study designs and consenting procedures tailored to the population’s specific concerns may promote inclusion of a broader eligible patient population [